Effect of Cysteamine on Cell Growth and IgG4 Production in Recombinant Sp2.0 Cells.

Jahandar, Hoda; Vaziri, Behrouz; Nematollahi, Leila; Afsharirad, Tayebeh; Mirabzadeh, Esmat; Torkashvand, Fatemeh; Khalaj, Vahid

Jahandar, Hoda; Vaziri, Behrouz; Nematollahi, Leila; Afsharirad, Tayebeh; Mirabzadeh, Esmat; Torkashvand, Fatemeh; Khalaj, Vahid.

Afiliación

Jahandar H; Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Vaziri B; Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Nematollahi L; Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Afsharirad T; Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Mirabzadeh E; Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Torkashvand F; Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Khalaj V; Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.

Iran J Pharm Res ; 14(1): 177-87, 2015.

Article en En | MEDLINE | ID: mdl-25561924

Palabras clave

Cysteamine; IgG4; Monoclonal antibody; Protein disulfide isomerase; Sp2.0 cells; Thiol reducing agents

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Iran J Pharm Res Año: 2015 Tipo del documento: Article País de afiliación: Irán Pais de publicación: Países Bajos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google